Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors

Authors

Philip R. Cohen, Touro University California
Razelle Kurzrock

Publication Date

6-18-2020

DOI

10.1016/J.JAAD.2020.02.052

ISSN

0190-9622

Recommended Citation

Cohen, P. R., & Kurzrock, R. (2020). Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors. Journal of the American Academy of Dermatology, 82(6), e253–e254. https://doi.org/10.1016/j.jaad.2020.02.052

PubMed ID

32109540